|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-30
|
$1,889,710
|
$18,897
|
EDELSON, RICHARD
|
YALE UNIVERSITY
|
|
|
Virotherapy for Neuroblastoma Stem Cells
|
1R21CA133663-01A1
|
$168,750
|
$168,750
|
CRIPE, TIMOTHY
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
|
VEGF blockade and alternative angiogenic pathways in neuroblastoma
|
1R01CA124644-01A2
|
$334,075
|
$334,075
|
YAMASHIRO, DARRELL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-35S1
|
$59,955
|
$600
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-35
|
$4,795,480
|
$47,955
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
Trk Expression and Inhibition in Human Neuroblastomas
|
2R01CA094194-06A1
|
$367,942
|
$367,942
|
BRODEUR, GARRETT
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
|
Translational Research in Cancer
|
2P30CA056036-09
|
$3,116,058
|
$31,161
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Translational Research in Cancer
|
3P30CA056036-09S1
|
$63,390
|
$634
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Transcriptional regulation of NC precursor formation
|
5R01CA114058-04
|
$243,714
|
$121,857
|
LABONNE, CAROLE
|
NORTHWESTERN UNIVERSITY
|
|
|
Training Program in Cancer Therapeutics
|
5T32CA117846-03
|
$346,294
|
$69,259
|
WALTZ, SUSAN
|
UNIVERSITY OF CINCINNATI
|
|
|
The Role of DNMT3B in the DNA Methylation of Cancer Cells
|
1R01CA129831-01A1
|
$306,257
|
$101,065
|
GODLEY, LUCY
|
UNIVERSITY OF CHICAGO
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-15S1
|
$91,948
|
$919
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-15S2
|
$49,383
|
$494
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-15S3
|
$83,152
|
$832
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-15
|
$5,084,061
|
$50,841
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
|
The oncogenic basis of Bmi-1 in neuroblastoma development
|
7R01CA124982-02
|
$291,722
|
$291,722
|
DING, HAN-FEI
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
|
|
The Genetic Basis of Neuroblastoma Tumorigenesis
|
1R01CA124709-01A2
|
$675,621
|
$675,621
|
MARIS, JOHN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
|
Targeting High-risk Neuroblastoma using high through put siRNA screening
|
Z01 BC 010806
|
$135,940
|
$74,767
|
Khan, Javed
|
CCR (NCI)
|
|
|
Swedish childhood cancers study
|
Z01 CP010183-00550
|
$2,170
|
$1,085
|
Anderson, William
|
DCEG (NCI)
|
|
|
Support for Human Specimen Banking in NCI-Supported Cancer Clinical Trials
|
5U24CA114766-04
|
$993,896
|
$198,779
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
|
Studies of Childhood Solid Tumors
|
5P01CA023099-30
|
$2,219,539
|
$221,954
|
HOUGHTON, PETER
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S1
|
$115,875
|
$1,159
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S2
|
$247,200
|
$2,472
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S3
|
$92,700
|
$927
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S4
|
$76,478
|
$765
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
Specialized Cancer Center Support Grant
|
5P30CA023100-24
|
$4,005,660
|
$40,057
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
South Texas Pediatric Minority Based CCOP
|
3U10CA052771-18S1
|
$84,400
|
$2,532
|
LANGEVIN, ANNE-MARIE
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
|
South Texas Pediatric Minority Based CCOP
|
5U10CA052771-18
|
$509,502
|
$15,285
|
LANGEVIN, ANNE-MARIE
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
Z01 BC 010958
|
$441,933
|
$132,580
|
Daar, Ira
|
CCR (NCI)
|
|
|
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
|
Z01 BC 010391
|
$441,458
|
$44,146
|
Tessarollo, Lino
|
CCR (NCI)
|
|
|
Role of Polyamines in MYCN-Amplified Neuroblastoma
|
3R01CA111419-03S1
|
$77,504
|
$77,504
|
BACHMANN, ANDRE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
|
Role of Polyamines in MYCN-Amplified Neuroblastoma
|
5R01CA111419-03
|
$214,682
|
$214,682
|
BACHMANN, ANDRE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
|
Role of Neurotrophins in the Development of the Mammalian Nervous System
|
Z01 BC 010390
|
$441,458
|
$88,292
|
Tessarollo, Lino
|
CCR (NCI)
|
|
|
Role of Hypoxia in the regulation of cancer cell differentiation
|
5R01CA125021-02
|
$314,370
|
$314,370
|
YUN, ZHONG
|
YALE UNIVERSITY
|
|
|
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
|
Z01 BC 010788
|
$381,010
|
$304,808
|
Thiele-Galetto, Carol
|
CCR (NCI)
|
|
|
Regulation of Apoptosis in Ewing's Sarcoma and Neuroblastoma
|
Z01 SC 010058
|
$276,944
|
$276,944
|
Tsokos, Maria
|
CCR (NCI)
|
|
|
Radiologial Physics Center
|
5U10CA010953-40
|
$2,445,710
|
$24,457
|
IBBOTT, GEOFFREY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Quality Assurance Review Center
|
5U10CA029511-29
|
$1,826,277
|
$18,263
|
FITZGERALD, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
|
Prevention of neuroblastoma with histone deacetylase inhibitors
|
5R03CA128075-02
|
$54,000
|
$54,000
|
Liu, Tao
|
UNIVERSITY OF NEW SOUTH WALES
|
|
|
Plasminogen activator inhibitor-1 in tumor progression and metastasis
|
1R01CA129377-01A1
|
$239,794
|
$239,794
|
DeClerck, Yves
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
|
Phenotypic Plasticity in Human Neuroblastoma
|
5R01CA077593-07
|
$239,931
|
$239,931
|
ROSS, ROBERT
|
FORDHAM UNIVERSITY
|
|
|
Pediatric Oncology Branch Clinical Care and Education
|
Z01 BC 010764
|
$1,703,170
|
$170,317
|
Wayne, Alan
|
CCR (NCI)
|
|
|
Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma
|
Z01 BC 010789
|
$381,010
|
$304,808
|
Thiele-Galetto, Carol
|
CCR (NCI)
|
|
|
P53-Mediated G1/M Checkpoint Controls Altered by PPM1D
|
5R01CA079756-08
|
$238,892
|
$71,668
|
MERCER, W
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Optimizing Pro-Apoptotic Therapeutics With Kinase Inhibition in Neuroblastoma
|
1K08CA128925-01A1
|
$139,320
|
$139,320
|
Goldsmith, Kelly
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
|
Optimizing Immunotherapy for Neuroblastoma after BMT
|
5R01CA100030-05
|
$291,566
|
$291,566
|
JOHNSON, BRYON
|
MEDICAL COLLEGE OF WISCONSIN
|
|
|
Novel Compounds and a Mitochondria Target Against Cancer
|
5R01CA104561-05
|
$237,918
|
$71,375
|
OPIPARI, ANTHONY
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
NM23/NDP Kinases: a New Family of DNA Repair Enzymes
|
3R01CA076496-10S1
|
$25,080
|
$6,270
|
POSTEL, EDITH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
|
NF-kappaB N-myc in Oncogenic Pathways of the CNS
|
5K01CA118274-03
|
$154,783
|
$154,783
|
SITCHERAN, RAQUEL
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
|
Neuropeptide Y in neuroblastoma: growth, angiogenesis and future therapeutics.
|
5R01CA123211-03
|
$267,492
|
$267,492
|
KITLINSKA, JOANNA
|
GEORGETOWN UNIVERSITY
|
|
Total relevant funding to Neuroblastoma for this search: $18,652,247
|
